Skip to main content

Table 1 Clinical characteristics of the patients included in this study

From: Investigating the potential of proton therapy for hypoxia-targeted dose escalation in non-small cell lung cancer

Patient # Sex Age (years) cTNM UICC Stage GTV Volume (total (primary)) [cc]
1 M 66 T2N3M0 IIIb 95.2 (78.6)
2 F 46 T2N2M0 IIIa 191.1 (169.5)
3 M 65 T3N2M0 IIIa 190.1 (148.8)
4 M 64 T4N2M0 IIIb 230.2 (214.3)
5 F 65 T2N2M0 IIIa 86 (32.8)
6 M 66 T3N2M0 IIIa 107.4 (95.3)
7 M 60 T4N1M0 IIIb 862.4 (853.6)
8 M 71 T2N3M0 IIIb 97.3 (42.8)
9 M 77 T3N2M0 IIIa 304.9 (296.3)
10 M 82 T3N0M0 IIb 63.3 (63.3)